Nevertheless, a significant association was still found in the subgroup of patients with European ancestry between carriers of CYP2C19 LOF alleles and higher risk of stroke, after clopidogrel-based antiplatelet therapy. The gene discussed is CYP2C19; the disease is Stroke.